UroGen Pharma Ltd (URGN) — Working Capital to Net Assets Ratio
UroGen Pharma Ltd (URGN) has a Working Capital to Net Assets ratio of -150.4% as of March 2026. Working capital of $186.83 Million (current assets of $237.46 Million minus current liabilities of $50.63 Million) is measured against net assets of $-124.25 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See UroGen Pharma Ltd net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
UroGen Pharma Ltd Working Capital to Net Assets (2013–2025)
This chart shows how UroGen Pharma Ltd's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at -150.4%, reflecting working capital of $186.83 Million against net assets of $-124.25 Million USD. Check how tangible is UroGen Pharma Ltd's equity to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for UroGen Pharma Ltd (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for UroGen Pharma Ltd from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see URGN stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -132.4% | $139.61 Million | $-105.47 Million | $186.02 Million | $46.42 Million | ▲ +2482.5 pp |
| 2024 | -2614.9% | $230.19 Million | $-8.80 Million | $276.13 Million | $45.95 Million | ▼ -2403.3 pp |
| 2023 | -211.6% | $137.97 Million | $-65.21 Million | $169.19 Million | $31.21 Million | ▼ -94.1 pp |
| 2022 | -117.5% | $104.99 Million | $-89.36 Million | $128.91 Million | $23.92 Million | ▼ -1211.2 pp |
| 2021 | 1093.7% | $92.01 Million | $8.41 Million | $114.39 Million | $22.38 Million | ▲ +995.9 pp |
| 2020 | 97.7% | $94.18 Million | $96.36 Million | $115.62 Million | $21.44 Million | ▲ +26.1 pp |
| 2019 | 71.6% | $129.15 Million | $180.30 Million | $148.63 Million | $19.48 Million | ▼ -26.9 pp |
| 2018 | 98.5% | $88.78 Million | $90.09 Million | $102.24 Million | $13.46 Million | ▲ +0.1 pp |
| 2017 | 98.4% | $67.44 Million | $68.52 Million | $74.47 Million | $7.04 Million | ▼ -17.5 pp |
| 2016 | 115.9% | $18.90 Million | $16.31 Million | $22.04 Million | $3.14 Million | ▲ +17.4 pp |
| 2015 | 98.5% | $16.89 Million | $17.15 Million | $19.13 Million | $2.24 Million | ▲ +0.5 pp |
| 2014 | 98.0% | $3.40 Million | $3.47 Million | $4.29 Million | $891.00K | ▲ +0.8 pp |
| 2013 | 97.2% | $2.66 Million | $2.74 Million | $3.15 Million | $484.00K | — |